Jeffrey Small

4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease†

Leo R. Fitzpatrick, Ludwig Deml, Claudia Hofmann et al. · Inflammatory Bowel Diseases · 2010 · 66 citations · Full text

Medicine, Immunology, Pharmacology +17

The Black Hole Explorer: motivation and vision

Michael D. Johnson, Kazunori Akiyama, Rebecca Baturin et al. · 2024 · 63 citations · Full text

Natural Sciences, Astronomy, Physics +14

<i>In vitro</i> and <i>in vivo</i> effects of the probiotic <i>Escherichia coli</i> strain M-17: immunomodulation and attenuation of murine colitis

Leo R. Fitzpatrick, Jeffrey Small, Robert Hoerr et al. · British Journal Of Nutrition · 2008 · 54 citations · Full text

Life Sciences, Immunology, Microbiology +17

Effects of the Probiotic Formulation VSL#3 on Colitis in Weanling Rats

Leo R. Fitzpatrick, Kristy L Hertzog, Angela L Quatse et al. · Journal of Pediatric Gastroenterology and Nutrition · 2007 · 43 citations

Life Sciences, Immunology, Gastrointestinal Pharmacotherapy +14

Vidofludimus Inhibits Colonic Interleukin-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action

Leo R. Fitzpatrick, Jeffrey Small, R. Doblhofer et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 43 citations

Veterinary Medicine, Immunology, Pharmacology +17